IDT to acquire AITbiotech

Integrated DNA Technologies (IDT), a provider of synthetic nucleic acids for molecular biology applications, has entered into a definitive agreement to acquire the oligonucleotide synthesis business of AITbiotech — a Singapore-based company that provides a complete suite of genomics services to research, healthcare and biomedical industries in Asia.

The acquisition will see IDT expands its customer base across South-East Asia, making it possible for these additional customers to have access to the company’s broad range of products for genomic applications. AITbiotech will continue operations in its other core business areas.

“With this purchase, we further expand our presence in the region and look forward to welcoming AITbiotech customers to IDT,” said IDT founder and CEO Dr Joseph A Walder. “The entire Singapore scientific research market can now benefit from IDT’s unrivalled manufacturing capabilities, design expertise and fast turnaround times.”

AITbiotech’s founder and CEO, Alex Thian, added, “We share a commitment with IDT to produce consistently high-quality oligos and to provide personal service for customers. Both companies are working diligently to facilitate a smooth transition of the business and we are excited to begin this next chapter in the ever expanding Singapore market.”